What is the recommended erythromycin dose for pediatric patients?

Pediatric Erythromycin Dosing

For children aged >1 month, the standard erythromycin dose is 40-50 mg/kg/day divided into 4 doses (maximum 2 g/day), given for 14 days for pertussis treatment. 1

Age-Specific Dosing

Infants <1 Month

• Erythromycin is NOT preferred due to significant risk of infantile hypertrophic pyloric stenosis (IHPS)
• Azithromycin is the recommended alternative
• If erythromycin must be used when azithromycin is unavailable: 40-50 mg/kg/day in 4 divided doses
• Critical caveat: These infants require close monitoring for IHPS, which occurred in 7 out of 157 exposed infants in one cohort study (relative risk: infinity) 1

Infants >1 Month and Children

• 40-50 mg/kg/day in 4 divided doses for 14 days (maximum 2 g/day) 1, 2
• The FDA label confirms the general pediatric range of 30-50 mg/kg/day in equally divided doses 2
• For severe infections, this may be doubled but should not exceed 4 g/day 2

Indication-Specific Dosing

Pertussis Treatment

• 40-50 mg/kg/day in divided doses for 5-14 days (14 days preferred to prevent relapses) 1, 2

Chlamydia Infections

• Conjunctivitis of newborn: 50 mg/kg/day in 4 divided doses for at least 2 weeks 2
• Pneumonia of infancy: 50 mg/kg/day in 4 divided doses for at least 3 weeks 2

Intestinal Amebiasis

• 30-50 mg/kg/day in divided doses for 10-14 days 2

Important Clinical Considerations

Gastrointestinal side effects are the most common adverse effects and are dose-related. These include epigastric distress, abdominal cramps, nausea, vomiting, and diarrhea 1. Enteric-coated formulations or ester derivatives (like erythromycin ethylsuccinate) can be taken with food to minimize these effects 1.

Formulation matters: Erythromycin estolate at 40 mg/kg/day divided in 2 doses was equivalent to erythromycin ethylsuccinate at 60 mg/kg/day divided in 3 doses for pertussis treatment, with similar side effect profiles 3.

Duration is critical: A 14-day course is recommended for pertussis because relapses have been reported after 7-10 days of treatment 1.

Common Pitfalls to Avoid

• Never use erythromycin as first-line in infants <1 month - the IHPS risk is too high with potentially fatal consequences
• Parents must be counseled about IHPS signs (projectile vomiting, visible peristaltic waves) if erythromycin is prescribed to newborns 1
• Do not co-administer with astemizole, cisapride, pimazole, or terfenadine 1
• Ensure adequate treatment duration for pertussis (14 days) to prevent relapse 1